Table 2.
Study | System | Patients (n) | Lesion | Pretreatment Lesion Volume | Treatment Time | Lesion Volume Ablated (%) | Imaging Modality | Complications |
---|---|---|---|---|---|---|---|---|
Sujijantarat et al.74 | NeuroBlate | 25 | Radiation necrosis | 0.3–12.6 cc | NR | 65% | MRI | Seizure, hemiparesis, DVT |
Ahluwalia et al.63 | NeuroBlate | 42 | Metastasis, Radiation necrosis | 0.4–38.6 cm3 | NR | NR | MRI | Seizures, hemiparesis, cerebral edema |
Carpentier et al.75 | Visualase | 6 | Metastasis | 9–25 mm diameter | 30–225 sec | NR | MRI | None |
Carpentier et al.76 | Visualase | 7 | Metastasis | NR | 30–180 sec | 43%–50% contrast-enhancing tumor | MRI | Hemorrhage, cerebellar syndrome |
Rennert et al.73 | Neuroblate | 34 | Metastasis | NR | NR | NR | MRI | NR |
Abbreviations: MRI, magnetic resonance imaging; NR, not recorded.